Stock-Based Compensation (Stock-Settled Stock Appreciation Rights Grant Details) (Details) (Stock Settled Stock Appreciation Rights SARS [Member], USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Stock Settled Stock Appreciation Rights SARS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
SSSARs granted (in rights)	0	2
Weighted average grant date fair value per award		$ 10.14
Weighted average assumptions used in fair value calculations:
Risk-free interest rate		0.61%
Dividend yield		2.01%
Volatility factor of the expected market price of our common stock		23.00%
Weighted average expected life in years		2 years 8 months 5 days